Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Aspen API Clascoterone

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    breezula

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Clascoterone and Segesterone: New Development Opportunities
    Clascoterone and Segesterone: New Development Opportunities

    18 Dec 2025

    // PRESS RELEASE

    https://www.aspenapi.com/news/clascoterone-and-segesterone-new-development-opportunities-in-our-aspen-api-steroid-portfolio/

    PRESS RELEASE
    18 Dec 2025
    Share Share
    Cosmo Acne Treatment Could Be The Answer For Male Baldness
    Cosmo Acne Treatment Could Be The Answer For Male Baldness

    03 Dec 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/cosmo-shares-zoom-results-2-male-pattern-hair-loss-trials

    FIERCE PHARMA
    03 Dec 2025
    Share Share
    Cosmo, Glenmark Obtain European Market Approval For Winlevi
    Cosmo, Glenmark Obtain European Market Approval For Winlevi

    18 Nov 2025

    // EXPRESSPHARMA

    https://www.expresspharma.in/cosmo-and-glenmark-receives-market-authorization-for-winlevi-in-europe/

    EXPRESSPHARMA
    18 Nov 2025
    Share Share
    Sun Pharma's WINLEVI® Cream Reduces Sebum Levels in Acne
    Sun Pharma's WINLEVI® Cream Reduces Sebum Levels in Acne

    25 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/studies-show-sun-pharmas-winlevi-clascoterone-cream-1-reduces-sebum-levels-and-is-suitable-for-combination-with-other-commonly-used-topical-acne-medications-302286736.html

    PR NEWSWIRE
    25 Oct 2024
    Share Share
    Sun Pharma Highlights Dermatology Portfolio at Fall Conference
    Sun Pharma Highlights Dermatology Portfolio at Fall Conference

    25 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sun-pharma-announces-multiple-data-presentations-highlighting-its-dermatology-portfolio-to-be-featured-at-the-2024-fall-clinical-dermatology-conference-302286676.html

    PR NEWSWIRE
    25 Oct 2024
    Share Share
    FDA Confirms Para IV Patent Litigation for (Winlevi) Clascoterone
    FDA Confirms Para IV Patent Litigation for (Winlevi) Clascoterone

    09 Oct 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-winlevi-clascoterone-69274.pdf

    FDA
    09 Oct 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.